Reporter for the San Francisco Chronicle
Jaxon Van Derbeken on KCRW
More from KCRW
Should we re-frame our idea of ‘working class’ voters?
PoliticsDoes “working class” mean what it used to? Is fracking getting more attention than it deserves? Plus, KCRW examines what came out of one culture war in Lancaster, Pennsylvania.
Can Americans trust justice and national security amid Trump transition?
PoliticsWill Donald Trump reduce U.S. interventionism? Did President Biden open a can of worms by pardoning his son Hunter? Plus, KCRW looks at what justice means post-election.
Got parking in Inglewood? Congrats, you’re winning
TransportationWith the new stadiums in Inglewood, businesses with parking are thriving, while those without feel the city’s economic boom is passing them by.
Prop 3 is an insurance policy for same-sex couples, backers say
Election 2024Proposition 3 would enshrine the right for same-sex couples to marry in the California constitution. It would also repeal and replace language from 2008 that says otherwise.
Prop 4: Here’s what’s in California’s $10B climate bond measure
Climate changeTen billion dollars doesn’t go far when it comes to adapting to climate change, but the state has a lot of projects planned, should this bond measure pass.
Michael Tracey: Why working class Americans of all races voted for Trump
PoliticsReporting on the election often involves being glued to computer screens dictating the polling numbers around the country and using statistics revolving around race and gender to make…
Trump and Harris try distancing themselves from campaign mistakes
PoliticsKCRW provides an election outlook with a week to go. Can the electorate stop being driven by hate? Plus, what was the Washington Post’s real mistake?
Juan Cole: Where is the Middle East Heading?
PoliticsIn the 365 days following the events of Oct. 7, the situation in the Middle East is as complicated as ever.
Irvine police buys $150K Cybertruck, critics call it unnecessary
LawThe Irvine Police Department purchased a Tesla Cybertruck to promote its D.A.R.E drug program. But some taxpayers say the money should be spent elsewhere.